Get App Open
In App
Lending
Lending
Open App
you are here:

Alivus Life Sciences Ltd.

BSE: 543322 | NSE: ALIVUS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE03Q201024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 24, 16:01
924.00 1.65 (0.18%)
Volume
AVERAGE VOLUME
5-Day
26,938
10-Day
18,104
30-Day
22,947
5,904
  • Prev. Close

    922.35

  • Open Price

    925.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Oct 24, 15:46
924.15 3.00 (0.33%)
Volume
AVERAGE VOLUME
5-Day
143,667
10-Day
143,124
30-Day
273,579
176,536
  • Prev. Close

    921.15

  • Open Price

    926.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Alivus Life Sciences (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 2,339.84 2,184.77 2,047.84 2,087.45 1,861.40  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 2,339.84 2,184.77 2,047.84 2,087.45 1,861.40  
Total Operating Revenues 2,386.88 2,283.21 2,161.22 2,123.21 1,885.17  
Other Income 34.57 12.04 28.96 14.70 0.81  
Total Revenue 2,421.45 2,295.26 2,190.18 2,137.92 1,885.98  
EXPENSES  
Cost Of Materials Consumed 1,053.50 1,058.58 1,098.53 1,001.56 976.20  
Purchase Of Stock-In Trade 0.00 0.00 0.00 0.00 0.00  
Operating And Direct Expenses 2.43 3.17 2.48 2.66 1.82  
Changes In Inventories Of FG,WIP And Stock-In Trade 27.35 -56.57 -84.44 41.32 -70.70  
Employee Benefit Expenses 251.70 258.16 180.18 168.72 149.13  
Finance Costs 2.41 1.55 0.55 27.96 87.55  
Depreciation And Amortisation Expenses 60.61 53.45 42.09 37.88 33.39  
Other Expenses 369.32 345.63 322.18 292.89 237.65  
Total Expenses 1,767.32 1,663.97 1,561.57 1,572.99 1,415.03  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 654.13 631.29 628.61 564.93 470.94  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 654.13 631.29 628.61 564.93 470.94  
Tax Expenses-Continued Operations  
Current Tax 162.44 152.21 150.61 137.63 112.75  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 6.06 8.19 11.04 8.57 6.62  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 168.50 160.40 161.65 146.20 119.36  
Profit/Loss After Tax And Before ExtraOrdinary Items 485.63 470.89 466.96 418.72 351.58  
Profit/Loss From Continuing Operations 485.63 470.89 466.96 418.72 351.58  
Profit/Loss For The Period 485.63 470.89 466.96 418.72 351.58  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 39.63 38.43 38.11 35.63 32.61  
Diluted EPS (Rs.) 39.53 38.38 38.11 35.63 32.61  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 275.69 385.96 128.65 0.00  
Tax On Dividend 0.00 0.00 0.00 0.00 0.00  
Equity Dividend Rate (%) 250.00 1,125.00 1,050.00 1,050.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970